Drug factory · FDA FEI 1510437

Patheon Pharmaceuticals Inc.

2110 E Galbraith Rd., Cincinnati, OH, United States

United States: 1

Problems found, fixed voluntarily at FDA's last inspection, Sep 26, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

15 drug inspections on record since 2010: 5 with no problems, 10 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
Acetaminophen and BenzhydrocodoneMakes it, tests it, packages it and labels it Zevra Therapeutics, Inc. 70040-0145, 70040-0167, 70040-0189
Amlodipine and PerindoprilatMakes it, tests it, packages it and labels it Adhera Therapeutics, Inc. 72931-010, 72931-011, 72931-012
AspirinMakes it New Haven Pharmaceuticals, Inc. 58487-001
Aspirin and OmeprazoleMakes it, packages it and labels it Aralez Pharmaceuticals Us Inc., Pharmaceutika Ltd 70347-081, 70347-325, 73568-004 +1
BrepocitinibMakes it, tests it, packages it and labels it Priovant Therapeutics, Inc. 87211-030
BromocriptineMakes it Avvisto Therapeutics LLC 73515-123
BudesonideMakes it Calliditas Therapeutics AB 81749-004
BuspironeMakes it New Horizon Rx Group, LLC 58517-340
CrofelemerMakes it Napo Pharmaceuticals, Inc. 70564-802
DoxepinMakes it Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven 44183-103, 44183-106
EluxadolineMakes it, tests it and packages it Allergan, Inc. 61874-075, 61874-100
GemifloxacinMakes it Merus Labs International Inc. 44001-321
HydroxyzineMakes it, tests it, packages it and labels it Amneal Pharmaceuticals, NCS HealthCare of KY, Inc dba Vangard Labs 0115-1803, 0115-1804, 0615-8419 +1
LisdexamfetamineMakes it, tests it and packages it Takeda Pharmaceuticals America, Inc. 59417-101, 59417-102, 59417-103 +10
NifedipineMakes it, tests it, packages it and labels it Elite Pharmaceutical Solution, Inc., Elite pharmaceutical Technology (Shanghai) Co., Ltd 70807-503, 72214-503
OxycodoneMakes it, packages it and labels it Collegium Pharmaceutical, Inc. 24510-110, 24510-115, 24510-120 +2
PerindoprilatMakes it, tests it, packages it and labels it Xoma (us) LLC 76234-000, 76234-001, 76234-002
RifampinTests it and packages it Sanofi-Aventis U.S. LLC 0068-0597
TapentadolMakes it Collegium Pharmaceutical, Inc. 24510-058, 24510-116, 24510-174 +2
TazemetostatMakes it Epizyme, Inc. 72607-100
TenapanorMakes it Ardelyx, Inc. 73154-110, 73154-120, 73154-130
VigabatrinMakes it and tests it Lundbeck Pharmaceuticals LLC 67386-111, 67386-211

FDA inspection history

EndedResultProgramProblems noted
Sep 26, 2025Problems found, fixed voluntarilyDrug Quality Assurance3
Apr 21, 2023No problems foundDrug Quality Assurance—
Jan 14, 2020No problems foundDrug Quality Assurance—
Feb 14, 2018Problems found, fixed voluntarilyDrug Quality Assurance6
Mar 2, 2017Problems found, fixed voluntarilyDrug Quality Assurance1
Mar 11, 2016Problems found, fixed voluntarilyDrug Quality Assurance—
Oct 30, 2014Problems found, fixed voluntarilyDrug Quality Assurance—
Jun 18, 2014No problems foundDrug Quality Assurance—
Aug 26, 2013Problems found, fixed voluntarilyDrug Quality Assurance—
May 13, 2013Problems found, fixed voluntarilyDrug Quality Assurance—
Aug 16, 2012Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 12, 2012Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 24, 2011Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 31, 2011No problems foundDrug Quality Assurance—
Mar 24, 2010No problems foundDrug Quality Assurance—

What inspectors wrote down

From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.

Sep 26, 2025 inspection

Feb 14, 2018 inspection

Mar 2, 2017 inspection

Registered with FDA for: analysis; api manufacture; label; manufacture; pack.